secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001493152-22-029849
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant stockholders approve 8.5M share increase in 2018 Equity Incentive Plan
----------------------------------------------------------------------------

- Stockholders approved Second Amended and Restated 2018 Equity Incentive Plan on October 26, 2022.
- Amendment increases shares available for issuance by 8,500,000 to a total capped by plan terms.
- Other plan provisions unchanged; plan expires July 31, 2028 unless earlier terminated.
- All six director nominees elected with >81.7M votes each; auditor ratified; say-on-pay approved.
- Plan vote: 82,054,439 for, 809,383 against, 3,618 abstentions, 2,002,504 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/0001493152-22-029849-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222029849/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029849

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer